Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 1)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00116714

Enrollment

4968

Registered

2005-07-01

Start date

2001-10-31

Completion date

2008-10-31

Last updated

2011-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

rheumatoid arthritis, RA, DMARD

Brief summary

The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated that study data may help improve the quality of information upon which clinical decisions are based.

Interventions

DRUGDMARD

All subjects were required to initiate, add or change DMARD therapy at study entry.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Fulfillment of the 1987 American Rheumatism Association criteria for RA * Currently requiring a new DMARD (change or addition)

Exclusion criteria

* Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol * Nursing or pregnant women * Patients with active infection

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026